Laser scanning cytometry in pathology of solid tumors

Acta Cytologica

Volumn 41, Issue 1, 1997, Pages 98-108

  Gorczyca, Wojciech ^a,b   Darzynkiewicz, Zbigniew ^a,c   Melamed, Myron R ^a,b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Department of Pathology ^*  (United States)

^c Cancer Research Institute   (United States)

Author keywords

Apoptosis; Cyclins; Estrogen receptors; Immunohistochemistry; Ki 67; Laser scanning cytometry; Ploidies

Indexed keywords

BROXURIDINE; CYCLIN B; DNA; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CELL CYCLE; CELL PROLIFERATION; CYTOMETRY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER; PLOIDY; PRIORITY JOURNAL; SOLID TUMOR;

EID: 0031041252     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000332313     Document Type: Article

References (74)

1. Bartkova J, Lukas J, Strauss M, Bartek J: Cyclin D 1 aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 1995;10:775-778
2. Battifora H, Mehta P, Ahn C: Estrogen receptor immunohis-tochemical assay in paraffin-embeded tissue: A better gold standard? Appl Immunohistochem 1993;1:39-45
3. Czerniak B, Darzynkiewicz Z, Herz F, Wersto RP, Koss LG: Flow cytometry in clinical oncology: Cell cycle and DNA ploidy in assessing tumor behavior. Mater Med Pol 1989; 21:3-9
4. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F: Features of apoptotic cells measured by flow cytometry. Cytometry 1992;13:795-808
5. Darzynkiewicz Z, Gong J, Juan G, Ardelt B, Traganos F: Cytometry of the cyclin proteins. Cytometry 1996;25:1-13
6. Darzynkiewicz Z, Traganos F, Gong J: Expression of cell cycle specific proteins cyclins as a marker of the cell cycle independent of DNA content. Meth Cell Biol 1994;41:422-435
7. Dolbeare F, Gratzner HG, Pallavicini MG, Gray JW: Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci USA 1983; 80:5573-5577
8. Dolbeare F, Seleden JR: Immunochemical quantitation of bromodeoxyuridine: Application to cell-cycle kinetics. In Flow Cytometry. Edited by Z Darzynkiewicz, JP Robinson, HA Crissman. San Diego, Academic Press, 1994, pp 297-315
9. Dolzhanskiy A, Basch RS: Flow cytometric determination of apoptosis in heterogeneous cell populations. J Immunol Methods 1995;180:131-140
10. Domagala W, Lasota J, Bartkowiak J, Weber K, Osborn M: Vimentin is preferentially expressed in human carcinomas with low estrogen receptor and high Ki-67 growth fraction. Am J Pathol 1990;136:219-227
11. Dutta A, Chandra R, Leiter LM, Lester S: Cyclins as markers of tumor proliferation: Immunocytochemical studies in breast cancer. Proc Natl Acad Sci USA 1995;92:5386-5390
12. Ellis PA, Makris A, Burton SA, Titley J, Ormerod MG, Salter J, Powles T, Smith IE, Dewset M: Comparison of MIB-1 proliferation index with S phase fraction in human breast carcinomas. Br J Cancer 1996; 73:640-643
13. Elstein KH, Thomas DJ, Zucker RM: Factors affecting flow cytometric detection of apoptotic nuclei by DNA analysis. Cytometry 1995;21:170-176
14. Elstein KH, Zucker RM: Comparison of cellular and nuclear flow cytometric techniques for discriminating apoptotic subpopulations. Exp Cell Res 1994; 211:322-331
15. Esteban JM, Ahn C, Battifora H, Felder B: Predictive value of estrogen receptors evaluated by quantitative immunohisto-chemical analysis in breast cancer. Am J Clin Pathol 1994;102:S9-12
16. Esteban JM, Ahn C, Mehta P, Battifora H: Biologic significance of quantitative estrogen receptor immunohistochemi-cal assay by image analysis in breast cancer. Am J Clin Pathol 1994;102:158-162
17. Gee JMW, Douglas-Jones A, Hepburn P, Sharma AK, McClelland RA, Ellis IO, Nicholson EI: A cautionary note regarding the application of Ki-67 antibodies to paraffin-embedded breast cancers. J Pathol 1995;177:285-293
18. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Ger-lach C, Stahmer I, Kloth S, Brandt E, Flad HD: Immunobio-chemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991;138:867-873
19. 1 and cyclin E in several leukemic and solid tumor cell lines. Cancer Res 1994;54:4285-4288
20. 2 cyclins measured in individual cells by multiparameter flow cytometry. Cell Prolif 1994; 27:357-371
21. Gorczyca W, Bigman K, Mittelman A, Ahmed T, Gong J, Melamed MR, Darzynkiewicz Z: Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia 1993;7:659-670
22. Gorczyca W, Bruno S, Darzynkiewicz RJ, Gong J, Darzynkiewicz Z: DNA strand breaks occurring during apoptosis: Their early in situ detection by the terminal de-oxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors. Int J Oncol 1992; 1:639-648
23. Gorczyca W, Bruno S, Melamed MR, Darzynkiewicz Z: Cell cycle-related expression of p120 nucleolar antigen in normal human lymphocytes and in cells of HL-60 and MOLT-4 leukemic lines: Effects of methotrexate, camptothecin, and teniposide. Cancer Res 1992;52:3491-3494
24. Gorczyca W, Gong J, Ardelt B, Traganos F, Darzynkiewicz Z: The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res 1993;53:3186-3192
25. Gorczyca W, Gong J, Darzynkiewicz Z: Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 1993;52:1945-1951
26. Gorczyca W, Kram A, Tuziak T, Darzynkiewicz Z, Melamed MR: Proliferating cell nuclear antigen in archival surgical specimens of malignant lymphoma and metastatic carcinoma: Immunohistochemical and flow cytometric analysis. Patol Pol 1993;44:121-128
27. Gorczyca W, Traganos F, Jesionowska H, Darzynkiewicz Z: Presence of DNA strand breaks and increased sensitivity of DNA in situ to denaturation in abnormal human sperm cells: Analogy to apoptosis of somatic cells. Exp Cell Res 1993; 207:202-205
28. Gorczyca W, Tuziak T, Kram A, Melamed MR, Darzynkiewicz Z: Detection of apoptosis-associated DNA strand breaks in fine-needle aspiration biopsies by in situ end labeling of fragmented DNA. Cytometry 1994;15: 169-175
29. Gratzner HG: Monoclonal antibody to 5-bromodeoxyuri-dine: A new reagent for detection of DNA replication. Science 1982;218:474-475
30. Hendricks JB, Wilkinson EJ: Comparison of two antibodies for evaluation of estrogen receptors in paraffin-embedded tumors. Mod Pathol 1993;6:765-770
31. Hockenberry DM: Bcl-2 in cancer, development and apoptosis. J Cell Sci 1995;18:51-55
32. Hunter T, Pines J: Cyclins and cancer. Cell 1991;66:1071-1074
33. Hunter T, Pines J: Cyclins and cancer: II. Cyclin D and CDK inhibitors come of age. Cell 1994;79:573-582
34. Isaacs JT: Role of programmed cell death in carcinogenesis. Envir Health Perspect (suppl) 1993;5:27-34
35. 2 primarily to the Golgi apparatus. EMBO J 1995;14: 1646-1654
36. 1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 1994;54:4813-4817
37. Kamentsky LA, Kamentsky LD: Microscope-based multiparameter laser scanning cytometer yielding data comparable to flow cytometry. Cytometry 1991;12:381-387
38. Kerr JFR, Wyllie AH, Curie AR: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1994;26:239-257
39. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB: Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 1994;54:380-385
40. Keyomarsi K, Pardee AB: Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 1993;90:1112-1116
41. Kong J, Ringer DP: Quantitative in situ image analysis of apoptosis in well and poorly differentiated tumors from rat liver. Am J Pathol 1995;147:1626-1632
42. Koss LG, Czerniak B: Image analysis and flow cytometry of tumors of prostate and bladder, with a comment on molecular biology of urothelial tumors. Monogr Pathol 1992;34: 112-128
43. Koss LG, Czerniak B, Herz F, Wersto RP: Flow cytometric measurements of DNA and other cell components in human tumors: A critical appraisal. Hum Pathol 1989;20:528-548
44. Li X, Darzynkiewicz Z: Labeling DNA strand breaks with BrdUTP: Detection of apoptosis and cell proliferation. Cell Prolif 1995;28:571-579
45. Li X, Melamed MR, Darzynkiewicz Z: Detection of apoptosis and DNA replication by differential labeling of DNA strand breaks with fluorochromes of different color. Exp Cell Res 1996;222:28-37
46. x cooperate to deregulate Gj control. Cancer Res 1996;55:4818-4823
47. Majno G, Joris I: Apoptosis, oncosis, and necrosis: An overview of cell death. Am J Pathol 1995;146:3-16
48. Martin Reay DG, Kamentsky LA, Weinberg DS, Hollister KA, Cibas ES: Evaluation of a new slide-based laser scanning cytometer for DNA analysis of tumors: Comparison with flow cytometry and image analysis. Am J Clin Pathol 1994;102:432-438
49. x overexpression in breast cancer. Oncogene 1995; 11:885-891
50. Melamed MR: Flow cytometry for detection and evaluation of urinary bladder carcinoma. Semin Surg Oncol 1992;8: 300-307
51. Nicholson RI, McClelland RA, Gee JM: Steroid hormone receptors and their clinical significance in cancer. Am J Clin Pathol 1995;48:890-895
52. Ostrowski ML, Chakraborty S, Laucirica R, Brown RW, Greenberg SD: Quantitative image analysis of MIB-1 im-munoreactivity: A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast. Analyt Quant Cytol Histol 1995;17:15-24
53. Pertschuk LP, Feldman JG, Kim YD, Braithwaite L, Schneider F, Braverman AS, Axiotis C: Estrogen receptor immuno-cytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Sp gamma in frozen sections or cytosol-based ligand-binding assays. Cancer 1996;77:2514-2519
54. Pines J: Arresting developments in cell-cycle control. Trends Biochem Sci 1994;19:143-145
55. Pines J: Cyclins and their associated cyclin-dependent kinases in the human cell cycle. Biochem Soc Trans 1993;21: 921-925
56. Pines J: Cyclins and cyclin-dependent kinases: Theme and variations. Adv Cancer Res 1995;66:181-212
57. Pines J: Cyclins, CDKs and cancer. Semin Cancer Biol 1995;6: 63-72
58. Poot M, Hoehn H, Kubbies M, Grossman A, Chen Y, Rabi-novitch PS: Cell-cycle analysis using continuous bromod-eoxyuridine labeling and Hoechst 33358-ethidium bromide bivariate flow cytometry. In Flow Cytometry. Edited by Z Darzynkiewicz, JP Robinson, HA Crissman. San Diego, Academic Press, 1994, pp 327-339
59. Qiao L, Gorczyca W, Pizzolo JG, Melamed MR, Darzynkiewicz Z: Flow cytometric characterization of proliferation-associated nuclear antigen (p105) during the cell cycle in normal lymphocytes and promyelocytic leukemia cells (HL-60). Analyt Quant Cytol Histol 1995;17:183-188
60. Querzoli P, Ferretti S, Albonico G, Magri E, Scapoli D, Indel-li M, Nenci I: Application of quantitative analysis to biologic profile evaluation in breast cancer. Cancer 1995;76:2510-2517
61. Raber MN, Barlogie B: DNA flow cytometry of human solid tumors. In Flow Cytometry and Sorting. Edited by MR Melamed, T Lindmo, ML Mendelsohn. New York, Wiley-Liss, 1990, pp 725-754
62. Remmele W, Schicketanz KH: Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer: Computer-assisted image analysis (QIC score) vs. subjective grading (IRS). Pathol Res Pract 1993;189:862-866
63. Rostagno P, Birtwisle I, Ettore F, Courdi A, Gioanni J, Namer M, Caldar C: Immunohistochemical determination of nuclear antigens by colour image analysis: Application for labeling index, estrogen and progesterone receptor status in breast cancer. Anal Cell Pathol 1994;7:275-287
64. Sahin AA, Ro J, Ro JY, Blick MB, el Naggar AK, Ordonez NG, Ordonez NG, Fritsche HA, Smith TL, Hortobagyi GN, Ayala AG: Ki-67 immunostaining in node-negative stage I/II breast carcinoma: Significant correlation with prognosis. Cancer 1991;68:549-557
65. Sahin AA, Ro JY, el Naggar AK, Wilson PL, Teague K, Blick M, Ayala AC: Tumor proliferative fraction in solid malignant neoplasms: A comparative study of Ki-67 immunos-taining and flow cytometric determinations. Am J Clin Pathol 1991;96: 512-519
66. Schultz DS, Katz RL, Patel S, Johnston D, Ordonez NG: Comparison of visual and CAS-200 quantitation of immunocyto-chemical staining in breast carcinoma samples. Analyt Quant Cytol Histol 1992;14:35-40
67. Sklarew RJ, Wali R, Auger M, Kidd LD, Katz RL: Estrogen receptor immunostaining patterns imaged in breast cancer fine needle aspirates. Analyt Quant Cytol Histol 1994;16: 293-305
68. Steck K, el Naggar AK: Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms. Cytometry 1994;17:258-265
69. Steck KD, McDonnell TJ, el-Naggar AK: Flow cytometric analysis of apoptosis and bcl-2 in human solid neoplasms. Cytometry 1995;20:154-163
70. Vermes I, Haanen C, Steffens Nakken H, Reutelingsperger C: A novel assay for apoptosis: Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995; 184:39-51
71. Wersto RP, Liblit RL, Koss LG: Flow cytometric DNA analysis of human solid tumors: A review of the interpretation of DNA histograms. Hum Pathol 1991;22:1085-1098
72. Williams NN, Daly JM: Flow cytometry and prognostic implications in patients with solid tumors. Surg Gynecol Obstet 1990;171:257-266
73. Wyllie AH: Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview. Cancer Metast Rev 1992;11:95-103
74. 1 oncogene. Mod Pathol 1995;8:560-567